Pfizer’s announcement yesterday that it had a COVID-19 vaccine candidate that was found to be more than 90% effective in preventing the virus, partially co-developed right here in Rockland, sent its stock and others soaring yesterday. WRCR’s Market Analyst Ken Mahoney of Mahoney Asset Management in Chestnut Ridge says, however, it will take some time before we get our hands on an actual vaccine…
County Executive Ed Day said he was proud to see the work being done right here in Rockland, calling the news promising for the country and the world. Pfizer’s primary research and development center is located in Pearl River, and they’ve been working on the vaccine with BioNTech based in Germany. Last week right here on “The Morning Show,” Orangetown supervisor Teresa Kenny said she saw lots of activity in the sky that told her something was happening at the Pfizer campus…
An external, independent Data Monitoring Committee found the vaccine offered protection 28 days after the initiation of the vaccination, which consists of a two-dose schedule. Pfizer says there have been no serious safety concerns found with the vaccine thus far. Pfizer and BioNTech will be submitting data later this month to the FDA, and hope to have 50 million vaccine doses ready in 2020 and up to 1.3 billion doses in 2021. Pfizer’s stock price ended the day yesterday up $2.80 or 7.69% at $39.20 a share.